Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features - 06/09/18
Doi : 10.1016/j.jaci.2018.06.016
Tom C. Chan, MD a, b, c, ∗, Riana D. Sanyal, ScB b, ∗, Ana B. Pavel, PhD b, Jacob Glickman, MA b, Xiuzhong Zheng, MSc c, Hui Xu, MSc b, Yung-Tsu Cho, MD a, Tsen-Feng Tsai, MD a, Huei-Chi Wen, MD, PhD b, Xiangyu Peng, MSc b, Inna Cueto, MSc c, James G. Krueger, MD, PhD c, Emma Guttman-Yassky, MD, PhD b 
a Department of Dermatology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
b Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai
c Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
| R.D.S. was supported by TL1 grant number TR001434 from the National Center for Advancing Translational Sciences, National Institutes of Health. |
|
| Disclosure of potential conflict of interest: J. G. Krueger has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. E. Guttman-Yassky is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, Medimmune/Astra Zeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB; and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 3
P. 1013-1017 - septembre 2018 Retour au numéro
Article précédent
- Synergistic cytokine effects as apremilast response predictors in patients with psoriasis
- Sandra Garcet, Kristine Nograles, Joel Correa da Rosa, Peter H. Schafer, James G. Krueger
- Mast cell activation test versus basophil activation test and related competing issues
- Salvaore Chirumbolo, Geir Bjørklund, Antonio Vella
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?